Erich Parker - Chemours President
| CC Stock | USD 21.74 0.08 0.37% |
President
Mr. Erich Parker was Senior Vice President of Corporationrationrate Communications, Chief Brand Officer of the Company. Mr. Parker was appointed Creative Director and Global Director of Corporationrationrate Communications of DuPont in 2010. He led the initiative to develop corporate positioning and its creative expression through branded content and program sponsorship with large international media outlets. In 2008, Mr. Parker was appointed Communications Leader for DuPonts Safety and Protection Platform. Prior to joining DuPont, Mr. Parker was principal of his own public relations and marketing communications firm based in Washington, D.C., and New York. Mr. Parker has also served as Executive Vice President of Association Issues Management Director of Communications for the American Academy of Actuaries founding publisher and Executive Editor of the magazine Contingencies and Public Affairs Aide for Renewable Energy to the Secretary of Energy, U.S. Department of Energy. 32 since 2015.
| Age | 67 |
| Tenure | 9 years |
| Address | 1007 Market Street, Wilmington, DE, United States, 19801 |
| Phone | 302 773 1000 |
| Web | https://www.chemours.com |
Chemours Management Efficiency
The company has Return on Asset (ROA) of 0.0397 % which means that for every $100 of assets, it generated a profit of $0.0397. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.1102 %, which means that it produced $0.1102 on every 100 dollars invested by current stockholders. Chemours' management efficiency ratios could be used to measure how well Chemours manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.03. The current year's Return On Capital Employed is expected to grow to -0.02. At present, Chemours' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 703.5 M, whereas Total Assets are forecasted to decline to about 7.5 B.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Andreas Opfermann | Linde plc Ordinary | 48 | |
| Erica McLaughlin | Cabot | 47 | |
| Brian Christian | Kronos Worldwide | 45 | |
| Hobart Kalkstein | Cabot | 54 | |
| Angela Busch | Ecolab Inc | 57 | |
| Roberto Inchaustegui | Ecolab Inc | 63 | |
| Rebecca Liebert | PPG Industries | 53 | |
| Larry Berger | Ecolab Inc | 63 | |
| Anup Sharma | LyondellBasell Industries NV | 45 | |
| Ramaparasad Vadlamannati | PPG Industries | 61 | |
| Patrick Schumacher | Olin Corporation | 49 | |
| Pat Dawson | Olin Corporation | 63 | |
| Torkel Rhenman | LyondellBasell Industries NV | 60 | |
| Colin Davie | Sherwin Williams Co | 55 | |
| Eduardo Menezes | Linde plc Ordinary | 56 | |
| Bryan Young | Sherwin Williams Co | 48 | |
| Janet Keckeisen | Kronos Worldwide | 68 | |
| Christophe Beck | Ecolab Inc | 56 | |
| Scott Kirkland | Ecolab Inc | 50 | |
| Dale Friedrichs | LyondellBasell Industries NV | 60 | |
| Wilbur Mok | Air Products and | 63 | |
Management Performance
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0397 |
Chemours Leadership Team
Elected by the shareholders, the Chemours' board of directors comprises two types of representatives: Chemours inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chemours. The board's role is to monitor Chemours' management team and ensure that shareholders' interests are well served. Chemours' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chemours' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dawn Farrell, Independent Chairman of the Board | ||
| Curtis Anastasio, Independent Director | ||
| Jonathan Lock, Senior Vice President and Chief Development Officer | ||
| Amber Wellman, Chief Officer | ||
| Matthew Abbott, Vice President - Digital and Analytics Platforms Leader | ||
| Shane Hostetter, Senior CFO | ||
| David Shelton, Senior Vice President, General Counsel, Secretary | ||
| Denise Dignam, President - Advanced Performance Materials | ||
| Curtis Crawford, Independent Director | ||
| Aditya Beri, Interim Business | ||
| Mary Cranston, Independent Director | ||
| Bradley Bell, Independent Director | ||
| Sheryl Telford, Chief Sustainability Officer | ||
| Ron Charles, Senior People | ||
| Erin Kane, Independent Director | ||
| Alisha Bellezza, President - Thermal & Specialized Solutions | ||
| Joseph Martinko, President Solutions | ||
| Susan Kelliher, Senior Vice President – Human Resources and Health Services | ||
| Gerardo Calderon, President Materials | ||
| Eugene Snell, President - Titanium Technologies | ||
| Sandra Rogers, Independent Director | ||
| Kurt Bonner, Ma Relations | ||
| Kristine Wellman, General VP | ||
| Sean Keohane, Independent Director | ||
| Sameer Ralhan, Chief Financial Officer, Senior Vice President, Treasurer | ||
| Shane CPA, Senior CFO | ||
| Guillaume Pepy, Independent Director | ||
| Brandon Ontjes, Vice Relations | ||
| Camela Wisel, Chief Accounting Officer, Vice President Controller | ||
| Mark Newman, Chief Operating Officer, Senior Vice President | ||
| Edwin Sparks, President - Chemical Solutions Business, Titanium Technologies | ||
| Erich Parker, Senior Vice President of Corporate Communications and Chief Brand Officer. | ||
| Brian Shay, Interim Officer | ||
| Mark Vergnano, President, Chief Executive Officer, Director | ||
| Richard Brown, Independent Chairman of the Board | ||
| Alvenia Scarborough, Senior Vice President - Corporate Communications and Chief Brand Officer |
Chemours Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chemours a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0397 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 6.94 B | ||||
| Shares Outstanding | 149.41 M | ||||
| Shares Owned By Insiders | 0.72 % | ||||
| Shares Owned By Institutions | 82.90 % | ||||
| Number Of Shares Shorted | 7.28 M | ||||
| Price To Earning | 25.49 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Diversified Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Dividend Share 1 | Earnings Share 0.5 | Revenue Per Share 38.519 | Quarterly Revenue Growth 0.009 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.